Omar Nadeem

A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma

G. Bianchi, S. Midha, Shahrier Hossain, 2023, Expert opinion on drug safety.

Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma

Jack Khouri, J. Berdeja, D. Catamero, 2024, Cancers.